Editorial Board — Medscape Ophthalmology

Board Members

  • Ronald C. Gentile, MD
    • Icahn School of Medicine
      The New York Eye and Ear Infirmary
      New York, New York
  • L. Jay Katz, MD
    • Sidney Kimmel Medical College
      Thomas Jefferson University
      Wills Eye Institute
      Philadelphia, Pennsylvania
 

Board Member Details

David M. Brown, MD
David M. Brown, MD

Associate Professor, Department of Ophthalmology, The Methodist Hospital, Weill Cornell College of Medicine; Director of Clinical Research, Retina Consultants of Houston, Houston, Texas

David M. Brown, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Genentech/Roche; Regeneron Pharmaceuticals, Inc.; Bayer HealthCare Pharmaceuticals; Novartis Pharmaceuticals Corporation; Avedrum Biotechnologies, Inc.; Santeen; Samsung; Senju; Ohr Pharmaceutical, Inc.; ChengduKanghong Biotechnology; REGENXBIO Inc.; Clearside Biomedical Inc.; Heidelberg; Optos; Carl Zeiss Meditec; Stealth Biotherapeutics; Apellis
Received research grant from: Genentech/Roche; Regeneron Pharmaceuticals, Inc.; Bayer HealthCare Pharmaceuticals; Novartis Pharmaceuticals Corporation; Avedrum Biotechnologies, Inc.; Santeen; Samsung; Senju; Heidelberg; Ohr Pharmaceutical, Inc.; ThromboGenics, Inc.; REGENXBIO Inc.; Clearside Biomedical Inc.
Received income in an amount equal to or greater than $250 from: Genentech/Roche; Regeneron Pharmaceuticals, Inc.; Bayer HealthCare Pharmaceuticals; Novartis Pharmaceuticals Corporation; Avedrum Biotechnologies, Inc.; Santeen; Samsung; Senju; Clearside Biomedical Inc.; Heidelberg; Optos; Carl Zeiss Meditec; Ohr Pharmaceutical, Inc.; REGENEXBIO Inc.; ChengduKanghong Biotechnology; Apellis; Stealth Biotherapeutics

David K. Coats, MD
David K. Coats, MD

Professor, Department of Ophthalmology and Pediatrics, Baylor College of Medicine; Chief, Department of Ophthalmology, Texas Children's Hospital, Houston, Texas

David K. Coats, MD, has disclosed no relevant financial relationships.

H. Burkhard Dick, MD, PhD
H. Burkhard Dick, MD, PhD

Professor and Chairman, Institute for Vision Science, Ruhr University Eye Hospital, Bochum, Germany

H. Burkhard Dick, MD, PhD, has disclosed the following relevant financial relationships:
Served as a board member (unpaid) for: Atia Medical/Shifamed, LLC; Avellino Lab USA, Inc.; Carl Zeiss Meditec; InfiniteVision Optics SAS; Medicem Group B.V.; Optical Express Inc.; Pharm-Allergan GmbH; Vivior AG; WebMD, LLC
Serve(d) as a consultant for: Avedro Inc.; Carl Zeiss Meditec; Johnson & Johnson Vision; Medicem Group B.V.; Optical Express Inc.; Polytech Domilens GmbH; RxSight, Inc.
Serve(d) as a consultant for (unpaid): AcuFocus, Inc.; Atia Medical/Shifamed, LLC; Avellino Lab USA, Inc.; Excel Lens Inc.
Received grants paid to the institution/grants pending from: AbbVie GmbH & Co. KG; AcuFocus, Inc.; Allergan GmbH; Avedro Inc.; Bayer Healthcare AG; Carl Zeiss Meditec; F. Hoffmann-La Roche Ltd; Implandata Ophthalmic Products GmbH; Johnson & Johnson Vision; Medicem Group B.V.; Novartis Pharmaceuticals Corporation GmbH; Ophtec BV; OSD Medical GmbH; Powervision, Inc.; ROWIAK GmbH; URSAPHARM Arzneimittel GmbH
Received payment for lectures including service on speakers bureau for: Johnson & Johnson Vision; Bausch + Lomb Inc.; Oculus Inc.; Pharm-Allergan GmbH; Thea Pharma GmbH
Holds patents from: Abbott; Morcher GmbH
Received royalties from: Oculus Inc.
Has stock/stock options in: AcuFocus, Inc.; Excel Lens Inc.; Implandtada Ophthalmic Products GmbH; RxSight, Inc.; Stroma Medical Corporation; Vivior Ltd.

Ronald C. Gentile, MD

Clinical Professor of Ophthalmology, Icahn School of Medicine; Co-Director, The Ocular Trauma Service, The New York Eye and Ear Infirmary, New York, New York

Ronald C. Gentile, MD, has disclosed no relevant financial relationships.

L. Jay Katz, MD
L. Jay Katz, MD

Director Emeritus, Glaucoma Service, Wills Eye Hospital; Professor, Department of Ophthalmology, Thomas Jefferson University, Philadelphia, Pennsylvania

L. Jay Katz, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Glaukos (Chief Medical Officer)
Serve(d) as a speaker or a member of a speakers bureau for: Allergan; Bausch and Lomb; Glaukos
Received research grant from: Diopsys; Heidelberg; Zeiss
Received income in an amount equal to or greater than $250 from: Allergan; Alcon; Bausch and Lomb; Glaukos